These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19602211)

  • 21. Evaluation of the overnight hold of whole blood at room temperature, before component processing: platelets (PLTs) from PLT-rich plasma.
    van der Meer PF; Cancelas JA; Vassallo RR; Rugg N; Einarson M; Hess JR;
    Transfusion; 2011 Jan; 51 Suppl 1():45S-49S. PubMed ID: 21223295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avoiding leukocyte contamination and early platelet activation in platelet-rich plasma.
    Trindade-Suedam IK; Leite FR; de Morais JA; Leite ER; Marcantonio EJ; Leite AA
    J Oral Implantol; 2007; 33(6):334-9. PubMed ID: 18240792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulation and distribution of 111-In-oxine-labeled autologous baboon platelet aggregates and buffy coat.
    Valeri CR; Macgregor H; Giorgio A; Ragno G
    Transfus Apher Sci; 2005 Apr; 32(2):139-46. PubMed ID: 15784447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of hematologic values and transforming growth factor-beta and insulin-like growth factor concentrations in platelet concentrates obtained by use of buffy coat and apheresis methods from equine blood.
    Sutter WW; Kaneps AJ; Bertone AL
    Am J Vet Res; 2004 Jul; 65(7):924-30. PubMed ID: 15281650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
    Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
    Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of a closed-system cell processor (ACP215) for automated preparation of washed platelet concentrates.
    Oikawa S; Sasaki D; Kikuchi M; Sawamura Y; Itoh T
    Vox Sang; 2012 Feb; 102(2):110-5. PubMed ID: 21770954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
    Albanyan AM; Harrison P; Murphy MF
    Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Enzyme immunoassay for the determination of serotonin in stored platelet concentrates].
    Ganschow I; Benn HP; Fischer R; Cassens U; Dittmer R; Kühnl P
    Beitr Infusionsther Transfusionsmed; 1994; 32():428-30. PubMed ID: 9480138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
    Sandgren P; Callaert M; Shanwell A; Gulliksson H
    Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods.
    Dijkstra-Tiekstra MJ; van der Schoot CE; Pietersz RN; Reesink HW
    Vox Sang; 2005 May; 88(4):275-7. PubMed ID: 15877650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
    Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
    Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and pathogen inactivation of double dose buffy coat platelet products using the INTERCEPT blood system.
    Abedi MR; Doverud AC
    J Vis Exp; 2012 Dec; (70):e4414. PubMed ID: 23242463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates.
    Zhang JG; Carter CJ; Devine DV; Scammell K; Weiss S; Gyongyossy-Issa MI
    Vox Sang; 2008 May; 94(4):299-305. PubMed ID: 18179681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation.
    Everts PA; Hoffmann J; Weibrich G; Mahoney CB; Schönberger JP; van Zundert A; Knape JT
    Transfus Med; 2006 Oct; 16(5):363-8. PubMed ID: 16999760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Apr; 48(4):723-30. PubMed ID: 18208415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
    Gubanova MN; Ayupova RF; Zhiburt EB
    Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality.
    Garner SF; Jones CI; Stephens J; Burns P; Walton J; Bernard A; Angenent W; Ouwehand WH; Goodall AH;
    Transfusion; 2008 Apr; 48(4):673-80. PubMed ID: 18194381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of platelet factor 4 and beta-thromboglobulin by profiling and liquid chromatography tandem mass spectrometry of supernatant peptides in stored apheresis and buffy-coat platelet concentrates.
    Wurtz V; Hechler B; Ohlmann P; Isola H; Schaeffer-Reiss C; Cazenave JP; Van Dorsselaer A; Gachet C
    Transfusion; 2007 Jun; 47(6):1099-101. PubMed ID: 17524104
    [No Abstract]   [Full Text] [Related]  

  • 40. [Platelet-leukocyte aggregates as a marker for platelet activation in platelet concentrates].
    Chakroun T; Abdelkefi S; Bouslama M; Houissa B; Zaier M; Miled A; Kortas M; Yacoub S
    Transfus Clin Biol; 2008 Sep; 15(4):148-53. PubMed ID: 18760949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.